Apyx Medical (APYX) Revenue (2011 - 2026)

Apyx Medical has reported Revenue for 16 years, with the latest figure at $12.5 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 32.45% year-over-year to $12.5 million; the trailing twelve-month figure through Mar 2026 stood at $55.9 million (up 18.22% YoY), and the FY2025 full-year result was $52.8 million, up 9.86% from the prior year.
• Revenue for Q1 2026 stood at $12.5 million, down from $19.2 million in the prior quarter.
• The five-year high for Revenue was $19.2 million in Q4 2025, with the low at $9.1 million in Q3 2022.
• Historically, Revenue has averaged $12.4 million across 5 years, with a median of $12.1 million in 2024.
• The largest YoY upside for Revenue was 44.63% in 2022 against a maximum downside of 25.04% in 2022.
• Apyx Medical's Revenue stood at $12.6 million in 2022, then increased by 16.26% to $14.7 million in 2023, then decreased by 3.0% to $14.2 million in 2024, then soared by 34.75% to $19.2 million in 2025, then plunged by 34.83% to $12.5 million in 2026.
• The last three Revenue figures came in at $12.5 million (Q1 2026), $19.2 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.